The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase III trial in progress comparing tislelizumab plus concurrent chemoradiotherapy (cCRT) with placebo plus cCRT in patients with localized esophageal squamous cell carcinoma (ESCC).
 
Wei-Hu Wang
No Relationships to Disclose
 
Jiancheng Li
No Relationships to Disclose
 
Tao Li
No Relationships to Disclose
 
Kuaile Zhao
No Relationships to Disclose
 
Rong Yu
No Relationships to Disclose
 
Wenqing Wang
No Relationships to Disclose
 
Mingqiu Chen
No Relationships to Disclose
 
Long Liang
No Relationships to Disclose
 
Jiyan Zou
Employment - BeiGene; BeiGene; BeiGene; BeiGene
 
Yidi Wang
Employment - BeiGene; BeiGene; BeiGene; BeiGene
 
Wei Shen
Employment - BeiGene; BeiGene; BeiGene; BeiGene
 
Zhe Wu
Employment - BeiGene; BeiGene; BeiGene; BeiGene
 
Zefen Xiao
No Relationships to Disclose